How much does rubicatin/rubitidin cost? Full analysis of price and cost performance

Lurbinectedin is a new type of anti-cancer drug mainly used to treat small cell lung cancer (SCLC) . It inhibits the growth and reproduction of tumor cells by inhibiting DNA transcription, and has a significant effect especially on patients who have failed traditional chemotherapy. Rubicatin's unique mechanism of action makes it an innovative option in the treatment of small cell lung cancer, especially in patients who have failed chemotherapy regimens. It can bring new hope.

Rubicadin was first launched in the European and American markets and has been approved by many countries and regions. As an anti-cancer drug, rubicatin is considered to have a very complementary effect to other traditional chemotherapy drugs, especially in the treatment of small cell lung cancer, where its application has allowed some patients to delay the progression of the disease. Its indications not only include small cell lung cancer, but also have potential application prospects in the treatment of other tumor types. However, currently in clinical practice, the most important use scenario is the treatment of small cell lung cancer.

However, the price of Rubicatin has also been a focus of concern for patients and the medical system. In December 2024, this drug has been approved by the State Food and Drug Administration for marketing. Due to the short time on the market, patients who want to use this drug may need to purchase drugs overseas or conduct clinical trials. The price of Rubicon is relatively high for the areas where it is already on the market. Taking the Hong Kong market as an example, the price of the original drug Rubicatin is 4mg per box, which is about more than 20,000 yuan (the price may change due to exchange rate fluctuations). In the European and American markets, especially the American market, the price of Rubicon is even higher, usually reaching more than 90,000 yuan per box. In comparison, the price of Rubicatin in the Singapore market is relatively affordable, about more than 30,000 yuan, but it still poses a financial burden to most patients. Currently, there are no generic versions of Rubicatin available globally.

Reference materials:https://www.zepzelca.com/